{"title":"姑息治疗临床药剂师对住院患者的描述工作的影响","authors":"Ibtihal Makki, K. Walker","doi":"10.1080/15360288.2023.2234263","DOIUrl":null,"url":null,"abstract":"Background: Palliative care (PC) patients are at high risk of polypharmacy, thereby imposing substantial burdens on patients, including increased pill burden, adverse drug events, falls, and even death. Studies show that most interventions to reduce unnecessary medications involve pharmacist recommendations. Deprescribing (DP) is an integral aspect of the role of pharmacists on PC teams. There is no literature to describe deprescribing opportunities among all PC patients when screened in a systematic fashion.","PeriodicalId":16645,"journal":{"name":"Journal of Pain & Palliative Care Pharmacotherapy","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of Palliative Care Clinical Pharmacists’ Deprescribing Efforts in Hospitalized Patients\",\"authors\":\"Ibtihal Makki, K. Walker\",\"doi\":\"10.1080/15360288.2023.2234263\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Palliative care (PC) patients are at high risk of polypharmacy, thereby imposing substantial burdens on patients, including increased pill burden, adverse drug events, falls, and even death. Studies show that most interventions to reduce unnecessary medications involve pharmacist recommendations. Deprescribing (DP) is an integral aspect of the role of pharmacists on PC teams. There is no literature to describe deprescribing opportunities among all PC patients when screened in a systematic fashion.\",\"PeriodicalId\":16645,\"journal\":{\"name\":\"Journal of Pain & Palliative Care Pharmacotherapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2023-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pain & Palliative Care Pharmacotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/15360288.2023.2234263\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ANESTHESIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pain & Palliative Care Pharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15360288.2023.2234263","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
Impact of Palliative Care Clinical Pharmacists’ Deprescribing Efforts in Hospitalized Patients
Background: Palliative care (PC) patients are at high risk of polypharmacy, thereby imposing substantial burdens on patients, including increased pill burden, adverse drug events, falls, and even death. Studies show that most interventions to reduce unnecessary medications involve pharmacist recommendations. Deprescribing (DP) is an integral aspect of the role of pharmacists on PC teams. There is no literature to describe deprescribing opportunities among all PC patients when screened in a systematic fashion.